-
Symbol
-
KLRS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
283K shares
-
Security Ownership
-
1.5%
Invus Public Equities, L.P. ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)
2025-07-29 - Invus Public Equities, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 283K shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).
This represents 1.5% percent ownership of the company.